Jennison Associates LLC Macrogenics Inc Transaction History

Jennison Associates LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$20.49 - $35.63 $558,598 - $971,345	-27,262 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$18.99 - $33.2 $102,640 - $179,446	-5,405 Reduced 16.55%	27,262 $868,000
Q4 2020 Feb 05, 2021	BUY	$19.41 - $26.0 $92,624 - $124,072	4,772 Added 17.11%	32,667 $747,000
Q3 2020 Nov 04, 2020	BUY	$24.69 - $31.6 $688,727 - $881,482	27,895 New	27,895 $703,000
Q4 2019 Feb 07, 2020	SELL	$7.95 - $12.27 $450,144 - $694,751	-56,622 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$12.44 - $17.48 $704,377 - $989,752	56,622 New	56,622 $722,000
Q4 2017 Jan 25, 2018	SELL	$16.19 - $20.3 $2.84 Million - $3.56 Million	-175,225 Closed	0 $0
Q3 2017 Nov 03, 2017	BUY	$15.52 - $18.94 $2.72 Million - $3.32 Million	175,225	175,225 $3.24 Million

132

55.4M

215K

238K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.